Holen Sie sich die Stockscreener-App
6.02
0.50%
-0.03
Handel nachbörslich:
5.98
-0.04
-0.66%
Schlusskurs vom Vortag:
$6.05
Offen:
$6.02
24-Stunden-Volumen:
200.34K
Relative Volume:
0.79
Marktkapitalisierung:
$318.29M
Einnahmen:
$81.06M
Nettoeinkommen (Verlust:
$-55.55M
KGV:
-5.2807
EPS:
-1.14
Netto-Cashflow:
$-47.98M
1W Leistung:
-3.53%
1M Leistung:
-31.75%
6M Leistung:
+72.49%
1J Leistung:
+106.16%
1-Tages-Spanne:
$5.96
$6.225
1-Wochen-Bereich:
$5.94
$6.72
52-Wochen-Spanne:
$2.03
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Vergleichen Sie SGHT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
6.02 | 319.87M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Hochstufung | Lake Street | Hold → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Sight Sciences CEO Badawi sells $148k in shares By Investing.com - Investing.com Canada
Sight Sciences (SGHT) chief legal officer sells $41,758 in stock By Investing.com - Investing.com Canada
Sight Sciences (SGHT) chief legal officer sells $41,758 in stock - Investing.com
Sight Sciences CEO Badawi sells $148k in shares - Investing.com
David Badawi Sells 4,836 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Paul Badawi Sells 22,362 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Jeremy Hayden Sells 6,308 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Insider Selling: Sight Sciences (NASDAQ:SGHT) CFO Sells 2,616 Shares of Stock - MarketBeat
Badawi, Sight Sciences CTO, sells $32k in shares - Investing.com
Badawi, Sight Sciences CTO, sells $32k in shares By Investing.com - Investing.com Canada
Sight Sciences, Inc.'s (NASDAQ:SGHT) 26% Share Price Plunge Could Signal Some Risk - simplywall.st
Americana Partners LLC Grows Stock Holdings in Sight Sciences, Inc. $SGHT - MarketBeat
Fed Watch: Is Sight Sciences Inc on track to beat earningsJuly 2025 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Sight Sciences’ Helix Surgical System Study: A Potential Game-Changer for Glaucoma and Cataract Treatment - MSN
Aug PostEarnings: Will Sight Sciences Inc benefit from sector rotationPortfolio Value Summary & Short-Term Trading Alerts - baoquankhu1.vn
Sight Sciences Releases Preliminary Q4 and 2025 Financial Results - VisionMonday.com
Sight Sciences (SGHT) Price Target Increased by 19.11% to 9.54 - Nasdaq
Sight Sciences reports Q4 revenue growth amid dry eye milestones By Investing.com - Investing.com Nigeria
Sight Sciences announces preliminary, unaudited fourth quarter and full year 2025 financial highlights - marketscreener.com
Sight Sciences Reports Preliminary Fourth Quarter and Full Year 2025 Financial Highlights - Quiver Quantitative
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights - marketscreener.com
Aug Rallies: Can Sight Sciences Inc be recession proofMarket Performance Recap & Fast Entry and Exit Trade Plans - baoquankhu1.vn
S P Trends: Will Sight Sciences Inc outperform tech stocks2025 Technical Overview & Technical Confirmation Alerts - baoquankhu1.vn
Sight Sciences (SGHT) – Analysts’ Recent Ratings Changes - Defense World
Looking At The Narrative For Sight Sciences SGHT After Medicare Coverage Shifts - Yahoo Finance
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of "Hold" by Brokerages - MarketBeat
This Insider Has Just Sold Shares In Sight Sciences - Sahm
Will Sight Sciences Inc. stock maintain dividend yieldMarket Weekly Review & Weekly Top Gainers Trade List - Улправда
Sight Sciences, Inc.'s (NASDAQ:SGHT) largest shareholders are individual investors with 30% ownership, institutions own 25% - Yahoo Finance
Sight Sciences (SGHT): chief legal officer Hayden sells $86k in stock - Investing.com UK
Rodberg, Sight Sciences CFO, sells $38,890 in SGHT stock By Investing.com - Investing.com South Africa
Sight Sciences (SGHT) CTO Badawi sells $73k in stock By Investing.com - Investing.com Canada
Sight Sciences (SGHT): chief legal officer Hayden sells $86k in stock By Investing.com - Investing.com South Africa
Sight Sciences (SGHT) CTO Badawi sells $73k in stock - Investing.com
Insider Selling: Sight Sciences (NASDAQ:SGHT) CFO Sells 4,405 Shares of Stock - MarketBeat
What analysts say about Sight Sciences Inc stockDividend Aristocrats List & Affordable Trading Strategies - earlytimes.in
Piper Sandler upgrades Sight Sciences stock rating to Overweight By Investing.com - Investing.com Nigeria
Published on: 2026-01-06 08:42:12 - earlytimes.in
What drives Sight Sciences Inc stock priceTechnical Analysis Insights & Capital Growth Strategies - earlytimes.in
Piper Sandler upgrades Sight Sciences stock rating to Overweight - Investing.com
Piper Sandler upgrades Sight Sciences on strong business prospects - TradingView — Track All Markets
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
The Truth About Sight Sciences Inc (SGHT): Silent Wall Street Underdog Or Total Flop? - AD HOC NEWS
Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge (NASDAQ:SGHT) - Seeking Alpha
Sight Sciences (SGHT) price target increased by 22.34% to 8.01 - MSN
Institutions profited after Sight Sciences, Inc.'s (NASDAQ:SGHT) market cap rose US$48m last week but individual investors profited the most - simplywall.st
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):